Literature DB >> 12082014

Nitric oxide mediates apoptosis induction selectively in transformed fibroblasts compared to nontransformed fibroblasts.

Stefanie Heigold1, Christine Sers, Wibke Bechtel, Boris Ivanovas, Reinhold Schäfer, Georg Bauer.   

Abstract

Nitric oxide (NO) mediates apoptosis induction in fibroblasts with constitutive src or induced ras oncogene expression, whereas nontransformed parental cells and revertants are not affected. This direct link between the transformed phenotype and sensitivity to NO-mediated apoptosis induction seems to be based on the recently described extracellular superoxide anion generation by transformed cells, as NO-mediated apoptosis induction in transformed cells is inhibited by extracellular superoxide dismutase (SOD), by SOD mimetics and by apocynin, an inhibitor of NADPH oxidase. Furthermore, nonresponsive nontransformed cells can be rendered sensitive for NO-mediated apoptosis induction when they are supplemented with xanthine oxidase/xanthine as an extracellular source for superoxide anions. As superoxide anions and NO readily interact in a diffusion-controlled reaction to generate peroxynitrite, peroxynitrite seems to be the responsible apoptosis inducer in NO-mediated apoptosis induction. In line with this conclusion, NO-mediated apoptosis induction in superoxide anion-generating transformed cells is inhibited by the peroxynitrite scavengers ebselen and FeTPPS. Moreover, direct application of peroxynitrite induces apoptosis both in transformed and nontransformed cells, indicating that peroxynitrite is no selective apoptosis inducer per se, but that selective apoptosis induction in transformed cells by NO is achieved through selective peroxynitrite generation. The interaction of NO with target cell derived superoxide anions represents a novel concept for selective apoptosis induction in transformed cells. This mechanism may be the basis for selective apoptosis induction by natural antitumor systems (like macrophages, natural killer cells, granulocytes) that utilize NO for antitumor action. Apoptosis induction mediated by NO involves mitochondrial depolarization and is blocked by Bcl-2 overexpression.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12082014     DOI: 10.1093/carcin/23.6.929

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  25 in total

1.  JS-K, a nitric oxide-releasing prodrug, induces breast cancer cell death while sparing normal mammary epithelial cells.

Authors:  Vanity McMurtry; Joseph E Saavedra; René Nieves-Alicea; Ann-Marie Simeone; Larry K Keefer; Ana M Tari
Journal:  Int J Oncol       Date:  2011-01-25       Impact factor: 5.650

2.  Mechanistic modelling suggests that the size of preneoplastic lesions is limited by intercellular induction of apoptosis in oncogenically transformed cells.

Authors:  Pavel Kundrát; Georg Bauer; Peter Jacob; Werner Friedland
Journal:  Carcinogenesis       Date:  2011-10-31       Impact factor: 4.944

3.  17-allylamino-17-demethoxygeldanamycin and MEK1/2 inhibitors kill GI tumor cells via Ca2+-dependent suppression of GRP78/BiP and induction of ceramide and reactive oxygen species.

Authors:  Teneille Walker; Clint Mitchell; Margaret A Park; Adly Yacoub; Mohamed Rahmani; Dieter Häussinger; Roland Reinehr; Christina Voelkel-Johnson; Paul B Fisher; Steven Grant; Paul Dent
Journal:  Mol Cancer Ther       Date:  2010-05-04       Impact factor: 6.261

4.  Nitric oxide-dependent changes in Schistosoma mansoni gene expression.

Authors:  Shanta M Messerli; William Morgan; Shanda R Birkeland; Jeremiah Bernier; Michael J Cipriano; Andrew G McArthur; Robert M Greenberg
Journal:  Mol Biochem Parasitol       Date:  2006-08-28       Impact factor: 1.759

5.  A perspective on the scientific, philosophical, and policy dimensions of hormesis.

Authors:  George R Hoffmann
Journal:  Dose Response       Date:  2009-01-19       Impact factor: 2.658

6.  Protective bystander effects simulated with the state-vector model.

Authors:  Helmut Schöllnberger; Peter M Eckl
Journal:  Dose Response       Date:  2007-06-26       Impact factor: 2.658

7.  Nitrosothiol Signaling in Anoikis Resistance and Cancer Metastasis.

Authors:  Sudjit Luanpitpong; Anand Krishnan V Iyer; Neelam Azad; Liying Wang; Yon Rojanasakul
Journal:  For Immunopathol Dis Therap       Date:  2012-01-01

8.  Nitric oxide regulates lung carcinoma cell anoikis through inhibition of ubiquitin-proteasomal degradation of caveolin-1.

Authors:  Pithi Chanvorachote; Ubonthip Nimmannit; Yongju Lu; Siera Talbott; Bing-Hua Jiang; Yon Rojanasakul
Journal:  J Biol Chem       Date:  2009-08-25       Impact factor: 5.157

9.  The contribution of N₂O₃ to the cytotoxicity of the nitric oxide donor DETA/NO: an emerging role for S-nitrosylation.

Authors:  Ahlam A Ali; Jonathan A Coulter; Claire H Ogle; Marie M Migaud; David G Hirst; Tracy Robson; Helen O McCarthy
Journal:  Biosci Rep       Date:  2013-03-28       Impact factor: 3.840

10.  Pegylated interferon-alpha plus taurine in treatment of rat liver fibrosis.

Authors:  Ilker Tasci; Mehmet Refik Mas; Sevil Atalay Vural; Salih Deveci; Bilgin Comert; Gunay Alcigir; Nuket Mas; Cemal Akay; Mithat Bozdayi; Cihan Yurdaydin; Hakan Bozkaya; Ozden Uzunalimoglu; Ahmet Turan Isik; Harun M Said
Journal:  World J Gastroenterol       Date:  2007-06-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.